The role of hyperleptinaemia and low values of interleukin 10 in de novo DSA production after kidney transplantation

被引:0
|
作者
Dedinska, Ivana [1 ,2 ,3 ,5 ]
Kleinova, Patricia [1 ,2 ,3 ]
Machalekova, Katarina [4 ]
Granak, Karol [1 ,2 ,3 ]
Vnucak, Matej [1 ,2 ,3 ]
Beliancinova, Monika [1 ,2 ,3 ]
机构
[1] Univ Hosp Martin, Transplant Ctr, Martin, Slovakia
[2] Comenius Univ, Jessenius Fac Med, Bratislava, Slovakia
[3] Univ Hosp Martin, Dept Internal Dis 1, Martin, Slovakia
[4] St Elizabeth Canc Inst, Dept Pathol, Bratislava, Slovakia
[5] Univ Hosp Martin, Transplant Ctr, Kollarova 2, Martin 03601, Slovakia
关键词
Leptin; IL-10; Protocol biopsy; Kidney transplantation; LEPTIN LEVELS; BODY-FAT; POLYMORPHISMS; ADIPONECTIN; ACTIVATION; DISEASE; WEIGHT; IL-10; ALPHA; INDEX;
D O I
10.1016/j.trim.2023.101982
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: White adipose tissue secretes a number of peptide hormones. The aim of this paper was to determine the role of leptin, adiponectin and interleukin-10 and interleukin-6 on the development of graft rejection in protocol biopsy after kidney transplantation. Methods: In a prospective analysis (n = 104), we monitored the values of leptin, adiponectin, IL -6, and IL -10 prior to the transplantation and in the 3rd month after the transplantation. The protocol biopsy of the graft was performed in the 3rd month after the transplantation. The group was divided into the following according to the biopsy result: negative result, IFTA 1, borderline, and DSA positive. Results: After adjusting for the differences in the baseline recipient and donor characteristics, we identified the hyperleptinaemia baseline (HR = 2.0444, P = 0.0341) and month 3 (HR = 49.8043, P < 0.0001) as independent risk factors for borderline changes in the protocol biopsy. The hyperleptinaemia baseline (HR = 7.4979, P = 0.0071) and month 3 (HR = 9.7432, P = 0.0057) are independent risk factors for de novo DSA positivity. A low value of IL -10 month 3 is a risk factor for de novo DSA positivity (HR = 3.0746, P = 0.0388). Conclusions: Higher leptin levels and low values of IL -10 might play a role in rejection and de novo DSA production.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Epitope Mismatch Predicts De Novo DSA After CNI Withdrawal in Low-Risk Kidney Transplant Recipients
    Nickerson, P.
    Wiebe, C.
    Formica, R.
    Tinckam, K.
    Poggio, E.
    Bunnapradist, S.
    Gibson, I.
    Rush, D.
    Samaniego, M.
    Gaber, O.
    Ilke, D.
    Bridges, N.
    Fairchild, R.
    Hricik, D.
    Heeger, P.
    TRANSPLANTATION, 2014, 98 : 137 - 137
  • [42] ABO Incompatibility in Kidney Transplantation Can Increase a Safety Margin of Epitope Mismatch Levels against De Novo DSA Production.
    Kobayashi, T.
    Iwasaki, K.
    Okada, M.
    Horimi, K.
    Matsuoka, Y.
    Takeda, A.
    Goto, N.
    Narumi, S.
    Watarai, Y.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 589 - 589
  • [43] THE ROLE OF PRE-TRANSPLANT AND DE NOVO ALLOANTIBODIES IN KIDNEY TRANSPLANTATION
    Sushkov, A. I.
    Abramov, V. Y.
    Moysyuk, Y. G.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2011, 13 (01): : 84 - 91
  • [44] MEDIUM TERM OUTCOME OF DE NOVO DSA TREATED WITH OPTIMISED IMMUNOSUPPRESSION FOLLOWING KIDNEY TRANSPLANTATION IN CHILDREN
    Shenoy, Mohan
    Edwards, Liz
    Plant, Nicholas
    Brix, Christian
    Worthington, Judith
    PEDIATRIC NEPHROLOGY, 2023, 38 : S224 - S224
  • [45] De Novo DSA against Third Party Extension Vessels Used in Kidney and Pancreas Transplantation.
    Garg, N.
    Ellis, T.
    Redfield, R.
    Parajuli, S.
    Astor, B.
    Djamali, A.
    Mandelbrot, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 774 - 774
  • [46] De novo ulcerative colitis after kidney transplantation treated with infliximab
    Rikako Oki
    Sumi Hidaka
    Akiko Sasaki
    Shinichi Teshima
    Yasuhiro Mochida
    Katsunori Miyake
    Kunihiro Ishioka
    Hidekazu Moriya
    Takayasu Ohtake
    Shuzo Kobayashi
    CEN Case Reports, 2021, 10 : 500 - 505
  • [47] De novo ulcerative colitis after kidney transplantation treated with infliximab
    Oki, Rikako
    Hidaka, Sumi
    Sasaki, Akiko
    Teshima, Shinichi
    Mochida, Yasuhiro
    Miyake, Katsunori
    Ishioka, Kunihiro
    Moriya, Hidekazu
    Ohtake, Takayasu
    Kobayashi, Shuzo
    CEN CASE REPORTS, 2021, 10 (04) : 500 - 505
  • [48] INCIDENCE OF DE NOVO DIABETES AND ITS COMPLICATIONS AFTER KIDNEY TRANSPLANTATION
    Woodward, Robert S.
    Burroughs, T. E.
    Lentine, K. L.
    Brennan, D. C.
    Schnitzler, M. A.
    NEPHROLOGY, 2005, 10 : A98 - A98
  • [49] Efficacy of equoral in prophylactic immunosuppression after de novo kidney transplantation
    Zadrazil, Josef
    Al Jabry, Sadek
    Horak, Pavel
    Bachleda, Petr
    Gibejova, Agata
    Kamarad, Vojtech
    DIALYSIS & TRANSPLANTATION, 2007, 36 (11) : 602 - +
  • [50] De novo congestive heart failure after kidney transplantation.
    Lentine, KL
    Schnitzler, MA
    Abbott, KC
    Li, L
    Burroughs, TE
    Irish, W
    Brennan, DC
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 555 - 555